IQVIA’s Q2 earnings report looms — analysts expect a 7.1% revenue jump, up from last year’s 5.3%, as the company continues its strong track record of beating expectations. With stock up 7.9% in the past month and analysts pricing in a $232 target, investors are watching closely to see if IQVIA can sustain momentum amid a steady life sciences sector.

Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/fe6ae75100661458

Rss
Podden och tillhörande omslagsbild på den här sidan tillhör The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av, eller tillsammans med, Poddtoppen.